Nivolumab vs Radium Ra 223 Dichloride
Nivolumab vs Radium Ra 223 Dichloride: Overview
This comparison examines the pharmacological differences between Nivolumab and Radium Ra 223 Dichloride.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Nivolumab — 27 days.
Chemical Properties
Type: Nivolumab — Antibody; Radium Ra 223 Dichloride — Small molecule.